Skip to main content
. 2018 Dec 14;19:113. doi: 10.1186/s12863-018-0703-y

Fig. 3.

Fig. 3

Comparison of Chr5[CMYA5] DMR associated with bioavailable testosterone in males in (a) childhood (at 7.5 years of age), (b) adolescence (at 16.5 years of age)